# PT-141 for female sexual dysfunction: 12-week dose trial

Source: https://pepvault.app/research/pt-141-clayton-2016

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [PT-141](https://pepvault.app/research#pt-141)

Randomized trial · people

# PT-141: +0.7 vs +0.2 satisfying sexual events a month at 12 weeks

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In premenopausal women, the higher PT-141 doses added a small gain in satisfying sexual events over placebo, and nausea, flushing and headache were the side effects that came up.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 327
- **Published:** 2016
- **Journal:** Womens Health (Lond)

## What they tested

The team tested whether bremelanotide (PT-141), used under the skin as needed, works and is safe for premenopausal women with female sexual dysfunctions, and which dose fits best.

## How the study was done

A randomized, placebo-controlled dose-finding trial in premenopausal women with female sexual dysfunctions, with 327 women in the efficacy analysis. Women gave themselves a placebo (dummy shot) or PT-141 at 0.75, 1.25 or 1.75 mg under the skin when they chose to, over 12 weeks.

<!--promo-->

PepVault for iPhone

## Taking PT-141? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

In the pooled 1.25 and 1.75 mg arms, satisfying sexual events rose by +0.7 a month from the start, compared with +0.2 on placebo (p = 0.0180). The total score on the female sexual function index went up +3.6 versus +1.9 (p = 0.0017). The total score on the female sexual distress scale for desire, arousal and orgasm changed by -11.1 versus -6.8 (p = 0.0014). The side effects named were nausea, flushing and headache.

## What it doesn’t show

The trial ran 12 weeks and included only premenopausal women. The main comparison pooled the two higher doses against placebo rather than looking at each dose alone.

## The paper

Clayton et al. Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial. Womens Health (Lond). 2016.

- [PubMed (PMID 27181790)](https://pubmed.ncbi.nlm.nih.gov/27181790/)
- [The paper (DOI 10.2217/whe-2016-0018)](https://doi.org/10.2217/whe-2016-0018)
- [ClinicalTrials.gov (NCT01382719)](https://clinicaltrials.gov/study/NCT01382719)

## The compound

- [PT-141: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)

## With this study

### PT-141

- [PT-141: the full reference](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/pt-141-10mg)

### Studies

- [PT-141: side-effect dropouts far higher than placebo in re-analysis](https://pepvault.app/research/pt-141-spielmans-2021)
- [PT-141: nausea in 40.0% vs 1.3% on placebo in phase 3 safety data](https://pepvault.app/research/pt-141-clayton-2022)
- [All 3 studies](https://pepvault.app/research#pt-141)

### Compared with

- [PT-141 vs Melanotan II](https://pepvault.app/peptides/compare/pt-141-vs-melanotan-ii)
- [PT-141 vs Oxytocin](https://pepvault.app/peptides/compare/pt-141-vs-oxytocin)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

## More studies on PT-141

- [PT-141: side-effect dropouts far higher than placebo in re-analysis](https://pepvault.app/research/pt-141-spielmans-2021) Meta-analysis · people · 2021
- [PT-141: nausea in 40.0% vs 1.3% on placebo in phase 3 safety data](https://pepvault.app/research/pt-141-clayton-2022) Systematic review · people · 2022
- [Every study on PT-141](https://pepvault.app/research#pt-141)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking PT-141? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking PT-141? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### PT-141

- [PT-141: the full reference](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/pt-141-10mg)

### Studies

- [PT-141: side-effect dropouts far higher than placebo in re-analysis](https://pepvault.app/research/pt-141-spielmans-2021)
- [PT-141: nausea in 40.0% vs 1.3% on placebo in phase 3 safety data](https://pepvault.app/research/pt-141-clayton-2022)
- [All 3 studies](https://pepvault.app/research#pt-141)

### Compared with

- [PT-141 vs Melanotan II](https://pepvault.app/peptides/compare/pt-141-vs-melanotan-ii)
- [PT-141 vs Oxytocin](https://pepvault.app/peptides/compare/pt-141-vs-oxytocin)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Taking PT-141? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on PT-141](https://pepvault.app/research#pt-141)

## The library

- [PT-141](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
